Cargando…

Total elbow arthroplasty in rheumatoid arthritis: A population-based study from the Finnish Arthroplasty Register

Background and purpose Although total elbow arthroplasty (TEA) is a recognized procedure for the treatment of the painful arthritic elbow, the choice of implant is still obscure. We evaluated the survival of different TEA designs and factors associated with survival using data from a nationwide arth...

Descripción completa

Detalles Bibliográficos
Autores principales: Skyttä, Eerik T, Eskelinen, Antti, Paavolainen, Pekka, Ikävalko, Mikko, Remes, Ville
Formato: Texto
Lenguaje:English
Publicado: Informa Healthcare 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823192/
https://www.ncbi.nlm.nih.gov/pubmed/19562563
http://dx.doi.org/10.3109/17453670903110642
_version_ 1782177614129004544
author Skyttä, Eerik T
Eskelinen, Antti
Paavolainen, Pekka
Ikävalko, Mikko
Remes, Ville
author_facet Skyttä, Eerik T
Eskelinen, Antti
Paavolainen, Pekka
Ikävalko, Mikko
Remes, Ville
author_sort Skyttä, Eerik T
collection PubMed
description Background and purpose Although total elbow arthroplasty (TEA) is a recognized procedure for the treatment of the painful arthritic elbow, the choice of implant is still obscure. We evaluated the survival of different TEA designs and factors associated with survival using data from a nationwide arthroplasty register. Methods 1,457 primary TEAs for rheumatoid elbow destruction were performed during 1982 to 2006 in one hospital specialized in the treatment of rheumatoid arthritis (n = 776) and in 19 other hospitals (n = 681). The mean age of the patients was 59 years and 87% of the TEAs were performed in women. We selected different contemporary TEA designs, each used in more than 40 operations including the Souter-Strathclyde (n = 912), i.B.P./Kudo (n = 218), Coonrad-Morrey (n = 164), and NESimplavit/Norway (n = 63) to assess their individual survival rates. Kaplan-Meier analysis and the Cox regression model were used for survival analysis. Results The most frequent reason for revision was aseptic loosening (47%). We found no differences in survival rates between different TEA designs. We did, however, find a 1.5-fold (95% CI: 1.1–2.1) elevated risk of revision in unspecialized hospitals as compared to the one hospital specialized in treatment of rheumatoid arthritis. In the Souter-Strathclyde subgroup, there was a reduced risk of revision (RR 0.6, p = 0.001) in TEAs implanted over 1994–2006 as compared to those implanted earlier (1982–1993). The 10-year survivorship for the whole TEA cohort was 83% (95% CI: 81–86), which agrees with earlier reports. Interpretation The influence of implant choice on the survival of TEA is minor compared to hip and knee arthroplasties. Inferior survival rates of the TEAs performed in the unspecialized hospitals demonstrates the importance of proper indications, surgical technique, and postoperative follow-up, and endorses the need for centralization of these operations at specialized units.
format Text
id pubmed-2823192
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Informa Healthcare
record_format MEDLINE/PubMed
spelling pubmed-28231922010-02-18 Total elbow arthroplasty in rheumatoid arthritis: A population-based study from the Finnish Arthroplasty Register Skyttä, Eerik T Eskelinen, Antti Paavolainen, Pekka Ikävalko, Mikko Remes, Ville Acta Orthop Research Article Background and purpose Although total elbow arthroplasty (TEA) is a recognized procedure for the treatment of the painful arthritic elbow, the choice of implant is still obscure. We evaluated the survival of different TEA designs and factors associated with survival using data from a nationwide arthroplasty register. Methods 1,457 primary TEAs for rheumatoid elbow destruction were performed during 1982 to 2006 in one hospital specialized in the treatment of rheumatoid arthritis (n = 776) and in 19 other hospitals (n = 681). The mean age of the patients was 59 years and 87% of the TEAs were performed in women. We selected different contemporary TEA designs, each used in more than 40 operations including the Souter-Strathclyde (n = 912), i.B.P./Kudo (n = 218), Coonrad-Morrey (n = 164), and NESimplavit/Norway (n = 63) to assess their individual survival rates. Kaplan-Meier analysis and the Cox regression model were used for survival analysis. Results The most frequent reason for revision was aseptic loosening (47%). We found no differences in survival rates between different TEA designs. We did, however, find a 1.5-fold (95% CI: 1.1–2.1) elevated risk of revision in unspecialized hospitals as compared to the one hospital specialized in treatment of rheumatoid arthritis. In the Souter-Strathclyde subgroup, there was a reduced risk of revision (RR 0.6, p = 0.001) in TEAs implanted over 1994–2006 as compared to those implanted earlier (1982–1993). The 10-year survivorship for the whole TEA cohort was 83% (95% CI: 81–86), which agrees with earlier reports. Interpretation The influence of implant choice on the survival of TEA is minor compared to hip and knee arthroplasties. Inferior survival rates of the TEAs performed in the unspecialized hospitals demonstrates the importance of proper indications, surgical technique, and postoperative follow-up, and endorses the need for centralization of these operations at specialized units. Informa Healthcare 2009-08-07 2009-08-01 /pmc/articles/PMC2823192/ /pubmed/19562563 http://dx.doi.org/10.3109/17453670903110642 Text en Copyright: © Nordic Orthopedic Federation http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited.
spellingShingle Research Article
Skyttä, Eerik T
Eskelinen, Antti
Paavolainen, Pekka
Ikävalko, Mikko
Remes, Ville
Total elbow arthroplasty in rheumatoid arthritis: A population-based study from the Finnish Arthroplasty Register
title Total elbow arthroplasty in rheumatoid arthritis: A population-based study from the Finnish Arthroplasty Register
title_full Total elbow arthroplasty in rheumatoid arthritis: A population-based study from the Finnish Arthroplasty Register
title_fullStr Total elbow arthroplasty in rheumatoid arthritis: A population-based study from the Finnish Arthroplasty Register
title_full_unstemmed Total elbow arthroplasty in rheumatoid arthritis: A population-based study from the Finnish Arthroplasty Register
title_short Total elbow arthroplasty in rheumatoid arthritis: A population-based study from the Finnish Arthroplasty Register
title_sort total elbow arthroplasty in rheumatoid arthritis: a population-based study from the finnish arthroplasty register
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823192/
https://www.ncbi.nlm.nih.gov/pubmed/19562563
http://dx.doi.org/10.3109/17453670903110642
work_keys_str_mv AT skyttaeerikt totalelbowarthroplastyinrheumatoidarthritisapopulationbasedstudyfromthefinnisharthroplastyregister
AT eskelinenantti totalelbowarthroplastyinrheumatoidarthritisapopulationbasedstudyfromthefinnisharthroplastyregister
AT paavolainenpekka totalelbowarthroplastyinrheumatoidarthritisapopulationbasedstudyfromthefinnisharthroplastyregister
AT ikavalkomikko totalelbowarthroplastyinrheumatoidarthritisapopulationbasedstudyfromthefinnisharthroplastyregister
AT remesville totalelbowarthroplastyinrheumatoidarthritisapopulationbasedstudyfromthefinnisharthroplastyregister